» Articles » PMID: 37711259

Frailty After COVID-19: The Wave After?

Overview
Specialty Geriatrics
Date 2023 Sep 15
PMID 37711259
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 pandemic poses an ongoing public health challenge, with a focus on older adults. Given the large number of older persons who have recovered from COVID-19 and reports of long-lasting sequelae, there is reasonable concern that the COVID-19 pandemic may lead to a long-term deterioration in the health of older adults, i.e., a potential "wave of frailty." Therefore, it is critical to better understand the circumstances surrounding the development of frailty as a result of COVID-19, as well as the underlying mechanisms and factors contributing to this development. We conducted a narrative review of the most relevant articles published on the association between COVID-19 and frailty through January 2023. Although few studies to date have addressed the effects of COVID-19 on the onset and progression of frailty, the available data suggest that there is indeed an increase in frailty in the elderly as a result of COVID-19. Regarding the underlying mechanisms, a multicausal genesis can be assumed, involving both direct viral effects and indirect effects, particularly from the imposed lockdowns with devastating consequences for the elderly: decreased physical activity, altered diet, sarcopenia, fatigue, social isolation, neurological problems, inflammation, and cardiovascular morbidity are among the possible mediators. Since the COVID-19 pandemic is leading to an increase in frailty in the elderly, there is an urgent need to raise awareness of this still little-known problem of potentially great public health importance and to find appropriate prevention and treatment measures.

Citing Articles

Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review.

Hanage W, Schaffner W Infect Dis Ther. 2024; 14(Suppl 1):5-37.

PMID: 39739200 PMC: 11724833. DOI: 10.1007/s40121-024-01080-4.


Frailty as a Predictor of COVID-19 Mortality in the South Indian Population: An Observational Study.

Srivatsa N, Chandrasekaran N, Tazeem M, Vijayakumar P Cureus. 2024; 16(10):e70820.

PMID: 39493167 PMC: 11531665. DOI: 10.7759/cureus.70820.


Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers - An updated European Academy of Neurology consensus statement.

Filipovic S, Ozturk S, Bereczki D, Bodini B, Cavallieri F, Fanciulli A Eur J Neurol. 2024; 31(10):e16408.

PMID: 39088330 PMC: 11414794. DOI: 10.1111/ene.16408.


Association between inflammatory markers, body composition and frailty in home-dwelling elderly: an 8-year follow-up study.

Balsrud P, Ulven S, Ottestad I, Retterstol K, Schwab U, Holven K Geroscience. 2024; 46(6):5629-5641.

PMID: 38981983 PMC: 11494618. DOI: 10.1007/s11357-024-01279-w.


Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary.

Gaspar Z, Szabo B, Andrikovics H, Cegledi A, Rajmon M, Abraham A Geroscience. 2024; 46(3):2863-2877.

PMID: 38367195 PMC: 11009165. DOI: 10.1007/s11357-024-01099-y.


References
1.
Proal A, VanElzakker M . Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021; 12:698169. PMC: 8260991. DOI: 10.3389/fmicb.2021.698169. View

2.
Bektas A, Schurman S, Franceschi C, Ferrucci L . A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging?. Immun Ageing. 2020; 17:23. PMC: 7443812. DOI: 10.1186/s12979-020-00196-8. View

3.
Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L . Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services. BMC Health Serv Res. 2020; 20(1):1144. PMC: 7750006. DOI: 10.1186/s12913-020-06001-y. View

4.
Hirose T, Sawaya Y, Ishizaka M, Hashimoto N, Ito A, Endo Y . Characteristics of Japanese Older Adults Whose Trunk Muscle Mass Decreased during the COVID-19 Pandemic. Int J Environ Res Public Health. 2022; 19(18). PMC: 9517623. DOI: 10.3390/ijerph191811438. View

5.
Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View